Page 1

☑ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D. C. 20549 FORM 10 - K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30 , 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Nevada For the transition period from Commission file number 001-37823 Kintara Therapeutics , Inc. ( Exact name of registrant as specified in its charter ) ( State or other jurisdiction of incorporation or organization ) Title of each class Common Stock 12707 High Bluff Dr. , Suite 200 San Diego , CA , 92130 ( Address of principal executive offices ) ( Zip Code ) ( 858 ) 350-4364 ( Registrant's telephone number , including area code ) 99-0360497 ( I.R.S. Employer Identification No. ) Securities registered pursuant to Section 12 ( b ) of the Act : Trading Symbol ( s ) KTRA Name of each exchange on which registered The Nasdaq Capital Market Securities registered pursuant to Section 12 ( g ) of the Act : None . Indicate by check mark if the registrant is a well - known seasoned issuer as defined in Rule 405 of the Securities Act . □ Yes > No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15 ( d ) of the Act . □ Yes > No Indicate by check mark whether the registrant ( 1 ) has filed all reports required to be filed by Section 13 or 15 ( d ) of the Securities Exchange Act of 1934 during the preceding 12 months ( or for such shorter period that the registrant was required to file such reports ) , and ( 2 ) has been subject to such filing requirements for the past 90 days . > Yes ☐ No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S - T ( § 232.405 of this chapter ) during the preceding 12 months ( or for such shorter period that the registrant was required to submit such files ) . × Yes ☐ No Indicate by check mark whether the registrant is a large accelerated filer , an accelerated filer , a non - accelerated filer , smaller reporting company , or an emerging growth company . See the definitions of “ large accelerated filer ” , “ accelerated filer " , " smaller reporting company , " and " emerging growth company " in Rule 12b - 2 of the Exchange Act . Large accelerated filer Non - accelerated filer Emerging growth company ☐ ☑ ☐ Accelerated filer Smaller reporting company ☑ If an emerging growth company , indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 ( a ) of the Exchange Act . □ Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404 ( b ) of the Sarbanes - Oxley Act ( 15 U.S.C. 7262 ( b ) ) by the registered public accounting firm that prepared or issued its audit report . Indicate by check mark whether the registrant is a shell company ( as defined by Rule 12b - 2 of the Act ) □ Yes > No As of December 31 , 2020 , the aggregate market value of the issued and outstanding common stock held by non - affiliates of the registrant , based upon the closing price of our common stock of $ 1.28 was approximately $ 26.9 million . For purposes of the above statement only , all directors , named executive officers and 10 % shareholders are assumed to be affiliates . This determination of affiliate status is not necessarily a conclusive determination for any other purpose . Number of shares of common stock outstanding as of September 28 , 2021 was 43,174,989 . DOCUMENTS INCORPORATED BY REFERENCE - None